Evaluation of toxicity of β-tethymustine, a new anticancer compound, in mice

Cancer Letters

Volumn 138, Issue 1-2, 1999, Pages 107-114

  Ghosh, Manju ^a   Sadhu, Utpal ^a   Bhattacharya, Sudin ^a   Dutta, Susanta ^a   Bhattacharya, Bhupati ^a   Sanyal, Utpal ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Dalton's Lymphoma; Ehrlich ascites carcinoma; Mice; New anticancer agent; Sarcoma 180; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORMETHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TOXICITY; BONE MARROW TOXICITY; CONTROLLED STUDY; EHRLICH ASCITES TUMOR; HEMATOPOIESIS; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER TOXICITY; LYMPHOMA; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SARCOMA 180; SPLEEN;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD CELL COUNT; CARCINOMA, EHRLICH TUMOR; HEMOGLOBINS; IMIDAZOLES; IMIDAZOLIDINES; KIDNEY; LIVER; MALE; MICE; NAPHTHALENES; SPLEEN;

EID: 0033606111     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00384-X     Document Type: Article

References (13)

1. Ghosh M., Bhattacharya S., Sadhu U., Dutta S., Sanyal U. Evaluation of β-tethymustine, a new anticancer compound, in murine tumour models. Cancer Lett. 119:1997;7-12.
2. Zarafoenetis C.J.D. Methods for the examination of the blood. Kolmer J.A., Spaulding E.H., Robinson H.W. Approved Laboratory Techniques. 1969;39-126 Appleton-Century-Crofts, New York.
3. Mauck J.C., Davis J.E. Clinical enzymology. Sonnenwirth A.C., Jarett L. Gradwohl's Clinical Laboratory Methods and Diagnosis. 1980;305-323 C.V. Mosby, St. Louis.
4. Sadhu U., Ghosh M., Bhattacharya S., Dutta S., Das H., Sanyal U. Evaluation of toxicity of cypenhymustine, a new anticancer compound, in mice. Cancer Lett. 85:1994;65-72.
5. Roy M.R., Guhathakurta S., Roychowdhury J. Haematological changes in experimental tumours. Indian J. Med. Res. 74:1981;896-903.
6. De Govin R.L., Grund F.M., Gibson D.F. Erythropoietic insufficiency in mice with extramedullary tumour. Blood. 51:1978;33-43.
7. Delmonte L., Liebelt A.G., Liebelt R.A. Granulopoiesis and thrombopoiesis in mice bearing transplanted mammary cancer. Cancer Res. 26:1966;149-159.
8. Rivenson A., Schnelle V., Moroson H., Madden R., Herp A. Variable response of spleen to Ehrlich's tumour according to the physical form (ascitic or solid) of the tumour. Experientia. 37:1981;195-197.
9. Chatterjee T.K. Data Related to Mice. In: Handbook on Laboratory Mice and Rats. 1993;K.K. Chatterjee, Calcutta. pp. 21-22.
10. Eccleston E. Normal haematological values in rats, mice and marmosets. Archer R.K., Jeffcott L.B. Comparative Clinical Haematology. 1977;611-619 Blackwell Scientific Publications, Oxford.
11. Colvin M., Chabner B.A. Alkylating agents. Chabner B.A., Collins J.M. Cancer Chemotherapy - Principles and Practice. 1990;276-313 J.B. Lippincot Company, Philadelphia.
12. Hoagland H.C. Hematologic complications of cancer chemotherapy. Perry M.C. The Chemotherapy Source Book. 1992;498-507 Williams & Wilkins, Baltimore.
13. Sanyal U., Bhattacharya S., Sadhu U., Dutta S., Das H., Ghosh M. Evaluation of cypenhymustine, a new anticancer compound, in murine tumour models. Cancer Lett. 70:1993;1-6.